U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H13ClN2O
Molecular Weight 308.762
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PINAZEPAM

SMILES

ClC1=CC2=C(C=C1)N(CC#C)C(=O)CN=C2C3=CC=CC=C3

InChI

InChIKey=MFZOSKPPVCIFMT-UHFFFAOYSA-N
InChI=1S/C18H13ClN2O/c1-2-10-21-16-9-8-14(19)11-15(16)18(20-12-17(21)22)13-6-4-3-5-7-13/h1,3-9,11H,10,12H2

HIDE SMILES / InChI

Description

Pinazepam, a benzodiazepine derivative, differs from other drugs of its class by the presence of an unsaturated bond, the propargyl group, at the N-1 position. In animals, pinazepam controls anxiety and aggressiveness and exerts anticonvulsant activity. In clinical trials with open or controlled design, pinazepam, compared with diazepam, showed significant and purely anxiolytic action in patients suffering from anxiety with or without somatic manifestations, particularly in gastrointestinal disorders. Even though it is not a specific hypnotic drug, it seems to help patients in whom the physiological course of the sleep is disturbed. Pinazepam is used in the treatment of anxiety and insomnia associated with anxiety.

CNS Activity

Approval Year

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
Anxiety 5-20 mg/day in divided doses. Insomnia associated w/ anxiety 2.5-5 mg at bedtime.
Route of Administration: Oral